MS

Michael Scholl

CEO

Leukocare AG

Munich, Bavaria


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Leukocare AG
Industry
research
Employees
47.0
Seniority
C suite
Annual Revenue
5600000.0
Total Funding
17500000.0
Latest Funding
Venture (Round not Specified)

Technologies

Outlook Pardot Microsoft Office 365 Gmail Google Apps Amazon AWS Atlassian Cloud Salesforce Mobile Friendly Apache Remote Reviews

Keywords

high concentration formulations bsl1 bsl2 antibodies vaccines viral vectors rna lnps exosomes peptides proteins enzymes viruses particle characterization molecular modeling insilico longterm stability prediction lyo optimization molecular purity & integrity analysis colloidal & conformational stability analysis atmp bioinformaticsbased formulation technology platform stateoftheart design of experiment matrices biotechnology research drug product development formulation development optimization services developability assessment drug substance characterization stability studies primary packaging assessment non-gmp processing small scale manufacturing data science services forced degradation studies bioinformatics analytics biopharmaceuticals antibody formulation small molecules vaccine development therapeutic candidates stability testing quality attributes analytics methods manufacturing processes sterile formulation risk mitigation aqueous formulations complex molecule development in silico analysis ai in formulation custom formulation services buffer screening shelf life prediction in-use studies cmc developability tailored solutions fast tracking development assay development clinical manufacturing support drug development flexibility technological innovation scientific collaboration partnerships quality control in biopharma complex biological compounds advanced data analysis optimal formulations information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans